CCEP: Did the Calendar Gift in Q1 Just Make the Second Quarter Impossible to Defend?

Coca-Cola Europacific Partners (CCEP) reports earnings on May 19, 2026, with investors focused on whether the world's largest Coca-Cola bottler can sustain momentum amid a challenging European economic backdrop. The release comes as analysts debate whether the company's premium valuation—trading at 11x forward EBITDA versus peers at 7-8x—can be justified given deepening recession concerns in key markets like Germany and Italy.

Part 1: Earnings Preview

Coca-Cola Europacific Partners is the world's largest Coca-Cola bottler by revenue, operating across Western Europe, Australia, and the Asia-Pacific region. The company manufactures, distributes, and sells Coca-Cola products across multiple consumer channels, from retail to away-from-home venues.

CCEP is scheduled to report first-quarter 2026 results on May 19, 2026. Analysts expect full-year 2026 EPS of $5.00, representing 7.53% growth year-over-year. The most recently reported quarter delivered EPS of €4.26 for full-year 2025, up sharply from €3.08 in 2024. Comparing to the same quarter last year, the current estimate reflects continued earnings expansion as the company laps strong prior-year comparisons.

Three key themes define this earnings story:

European Economic Headwinds: The central concern is deepening recession risk across CCEP's core European markets. The IMF's latest world economic outlook has trended lower for countries like Germany and Italy, with estimates for the Euro region weakening. While ready-to-drink beverages are relatively resistant to economic slowdowns as consumer staples, the setup points to weaker demand in away-from-home channels including restaurants and entertainment venues—a critical revenue stream for bottlers.

Premium Valuation Under Pressure: CCEP's 11x EV/forward EBITDA multiple commands a significant premium to global bottler peers like Coca-Cola HBC AG at 7.9x and Mexico-based Coca-Cola FEMSA at similar levels. This valuation spread appears to reflect unique European headwinds and geopolitical risk premiums. The bearish case centers on whether company guidance and market estimates through 2027 will underperform as economic conditions deteriorate.

Growth Trajectory Moderation: According to consensus, topline growth is expected to reach 5.7% in 2026 and moderate toward 4.3% in 2027 and 3.4% in 2028. From an expected decline in EPS earlier in the cycle, the market sees earnings rebounding by 6.9% next year. However, with inflation and input costs stabilizing or trending lower, there remains considerable uncertainty in these estimates.

Analyst commentary ahead of the release reflects cautious optimism tempered by macro concerns. JPMorgan recently upgraded CCEP to Neutral with a $93 price target, citing stabilizing conditions but acknowledging the challenging setup. The consensus view among Wall Street analysts is that investors should monitor how management addresses European demand trends and whether guidance reflects the deteriorating economic outlook.

Part 2: Historical Earnings Performance

No historical earnings surprise data is available for recent quarters, limiting visibility into CCEP's track record of beating or missing estimates. The absence of quarterly EPS history makes it difficult to identify patterns in the company's reporting tendencies or consistency relative to analyst expectations.

However, full-year 2025 results showed strong performance with EPS of €4.26, up 38% from €3.08 in 2024, and revenue of €20.9 billion, up 2.3% year-over-year. Profit margin expanded to 9.3% from 6.9%, indicating operational efficiency gains despite modest topline growth. This suggests the company has been effective at managing costs and improving profitability even as revenue growth moderates.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 3: What Analysts Are Saying

Analyst sentiment on CCEP remains constructive with a Moderate Buy consensus, though the rating distribution reveals some caution. Of the 14 analysts covering the stock, 9 rate it a Strong Buy, while 4 assign Hold ratings and 1 maintains a Strong Sell. The average recommendation of 4.14 reflects solid bullish conviction, though not unanimous enthusiasm.

The consensus price target stands at $107.45, implying 16.3% upside from the current price of $92.41. Price targets range from a low of $81.00 to a high of $118.00, showing considerable dispersion in analyst views. The wide range suggests disagreement about how European economic headwinds and valuation premiums will resolve.

Analyst sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady. This stability suggests analysts are waiting for the earnings release and updated guidance before adjusting their views. The lack of recent upgrades or downgrades indicates the Street is in a holding pattern, balancing CCEP's strong operational execution against macro uncertainty.

Looking further out, analysts project full-year 2027 EPS of $5.50, representing 10.00% growth from 2026 estimates. Revenue is forecast to grow 3.6% annually over the next three years, slightly below the 3.8% growth forecast for the U.S. beverage industry. The consensus implies CCEP can sustain mid-single-digit revenue growth and high-single-digit earnings growth, though this outlook depends on European economic conditions stabilizing and the company maintaining its margin expansion trajectory.

Part 4: Technical Picture

The Barchart Technical Opinion has deteriorated sharply heading into earnings, shifting from a 40% Buy signal one month ago to a 40% Sell signal currently. Last week showed an 8% Buy, indicating the negative momentum accelerated in recent sessions. This rapid reversal suggests technical pressure is building as the stock approaches its earnings release.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative, with the stock losing ground in recent sessions
• Medium-term (Hold): Neutral reading suggests the intermediate trend remains balanced despite short-term weakness
• Long-term (50% Sell): Moderate sell signal reflects underlying weakness in the longer-term trend structure

Trend Characteristics: The trend is showing Minimum strength with a Weakening direction, indicating deteriorating momentum and fragile technical conditions heading into the earnings event.

The stock is trading at $92.41, positioned above only the 5-day moving average at $91.39 but below all other key moving averages. The price sits below the 10-day ($92.71), 20-day ($94.14), 50-day ($95.28), and 100-day ($95.38) moving averages, indicating a clear downtrend across multiple timeframes. The stock is also below its 200-day moving average at $92.89, though only marginally.

The options market is pricing a 6.72% expected move through the June 18 expiration, implying a trading range between $86.09 and $98.50. This expected move reflects elevated uncertainty around the earnings release and subsequent price action.

Key resistance now sits at the 10-day moving average near $92.71, with more significant overhead at the 20-day ($94.14) and 50-day ($95.28) levels. Support appears limited until the $86 area implied by options positioning. The overall technical setup is cautionary heading into earnings, with the stock in a downtrend, momentum weakening, and price action compressed below multiple moving averages. The combination of deteriorating technicals and elevated options-implied volatility suggests investors should prepare for potentially volatile post-earnings price action, with the technical backdrop offering little support if results or guidance disappoint.